Eisai to Present Latest Data on Lemborexant at SLEEP 2023
Tokyo-based Eisai will present eight poster presentations on its orexin receptor antagonist lemborexant (Dayvigo) at SLEEP 2023.
Stay updated with breaking news from Differential Effect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tokyo-based Eisai will present eight poster presentations on its orexin receptor antagonist lemborexant (Dayvigo) at SLEEP 2023.
We investigate whether corporate governance has differential effects on downside and upside risk. Intuitively, strong corporate governance should decrease the downside risk but increase the upside risk. However, using a large panel of 1164 non-financial Australian firms from 2001 to 2013, we find that strong corporate governance relates negatively not only to downside risk but also to upside risk. These findings are robust to alternative risk-taking and corporate governance proxies and alternative sample specifications. We also show that our main results are unaffected due to endogeneity bias ...
Many more infections. so more people are infected, more people are at risk of getting a serious illness in total. so really, we have to be quite cautious, take public health measures, we have to wear our masks. particularly if we are in crowded places. so it is really important, as the chief medical officer said, to prioritise those events that you want to go to and de—prioritise the other events. bud want to go to and de-prioritise the other events-_ other events. and as it clear at this stage _ other events. and as it clear at this stage from _ other events. and as it clear at this stage f...